Wake voters will cast their ballots for the local, state and federal elections on Nov. 3, 2026. Casey Toth File photo AI-generated summary reviewed by our newsroom. Read our AI Policy. More than 100 ...
Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...
Abstract: According to research, the vast majority of road accidents (90%) are the result of human error, with only a small percentage (2%) being caused by malfunctions in the vehicle. Smart vehicles ...
Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...
The AI startup Firebird Inc. has received US government approval to export Nvidia Corp. chips to Armenia for a supercomputer project in the country, part of a global push to expand artificial ...
When Nintendo revealed the Switch 2, it showcased the console's Game-Key Cards feature, which enables the storage of a small amount of data on the cartridge, with the remainder of the game being ...
Christian has three years of experience writing in the gaming industry, including guides and reviews, for publications such as Dualshockers, Attack of the Fanboy, and PC Invasion. He has been an avid ...
Shane Limbaugh (He/Him) is a Contributor from the US. While he hasn't been writing about games for very long he has certainly been playing them. His degree in Game Design and Criticism let him better ...
An examination of ethical and legal issues relating to the development and use of generative AI (GenAI), focusing on privacy and data security, intellectual property (IP), and commercial transactions.
In primary care clinics, implementing integrated strategies involving routine screening, assessment of symptoms, and provision of relevant care improved the rates of screening, diagnosis, and ...
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback